FDAnews
www.fdanews.com/articles/81849-crashing-the-stent-party

CRASHING THE STENT PARTY

October 21, 2005

Conor Medsystems is developing a new breed of stent that may have the power to swipe large swaths of business from rivals such as Johnson & Johnson and Boston Scientific. But the company's chief executive officer, Dr. Frank Litvack, has a controversial past, and there are thorny questions about potential conflicts of interest and litigation that could torpedo its fortunes.
BusinessWeek Online